Clinical features and treatment of world health organization grade II and III meningiomas in childhood: Report of 23 cases

Journal of Neurosurgery: Pediatrics

Volumn 10, Issue 5, 2012, Pages 423-433

  Wang, Xiao Qiang ^a   Jiang, Cheng Chuan ^a   Zhao, Lin ^a   Gong, Ye ^a   Hu, Jie ^a   Chen, Hong ^b  

^a Departments of Neurosurgery   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Bcl 2; High grade meningioma; MIB 1; Oncology; Progesterone receptor; Prognosis; Radiation therapy

Indexed keywords

PROTEIN BCL 2;

ADOLESCENT; ARTICLE; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SIZE; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CLINICAL FEATURE; CRANIAL NERVE PARALYSIS; EPILEPSY; FEMALE; FOLLOW UP; HEADACHE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; INTERVIEW; LAMINECTOMY; MALE; MENINGIOMA; NEUROFIBROMATOSIS; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RECURRENT CANCER; SCHOOL CHILD; VOMITING; WORLD HEALTH ORGANIZATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; NEOPLASM GRADING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; WORLD HEALTH ORGANIZATION;

EID: 84868360439     PISSN: 19330707     EISSN: 19330715     Source Type: Journal    
DOI: 10.3171/2012.7.PEDS12179     Document Type: Article

References (35)

1. Amirjamshidi A, Mehrazin M, Abbassioun K: Meningiomas of the central nervous system occurring below the age of 17: report of 24 cases not associated with neurofibromatosis and review of literature. Childs Nerv Syst 16:406-416, 2000
2. Arivazhagan A, Devi BI, Kolluri SV, Abraham RG, Sampath S, Chandramouli BA: Pediatric intracranial meningiomas -do they differ from their counterparts in adults? Pediatr Neurosurg 44:43-48, 2008
3. Asioli S, Senetta R, Maldi E, D'Ambrosio E, Satolli MA, Bussolati G, et al: "Benign" metastatic meningioma: clinicopathological analysis of one case metastasising to the lung and overview on the concepts of either primitive or metastatic meningiomas of the lung. Virchows Arch 450:591-594, 2007
4. Baser ME, Friedman JM, Wallace AJ, Ramsden RT, Joe H, Evans DG: Evaluation of clinical diagnostic criteria for neurofibromatosis 2. Neurology 59:1759-1765, 2002
5. Campbell BA, Jhamb A, Maguire JA, Toyota B, Ma R: Meningiomas in 2009: controversies and future challenges. Am J Clin Oncol 32:73-85, 2009
6. Caroli E, Russillo M, Ferrante L: Intracranial meningiomas in children: report of 27 new cases and critical analysis of 440 cases reported in the literature. J Child Neurol 21:31-36, 2006
7. Commins DL, Atkinson RD, Burnett ME: Review of meningioma histopathology. Neurosurg Focus 23(4):E3, 2007
8. Das A, Tan WL, Smith DR: Expression of the inhibitor of apoptosis protein survivin in benign meningiomas. Cancer Lett 193:217-223, 2003
9. Demirtaş E, Erşahin Y, Yilmaz F, Mutluer S, Veral A: Intracranial meningeal tumours in childhood: a clinicopathologic study including MIB-1 immunohistochemistry. Pathol Res Pract 196:151-158, 2000
10. Di Rocco C, Di Rienzo A: Meningiomas in childhood. Crit Rev Neurosurg 9:180-188, 1999
11. Gao X, Zhang R, Mao Y, Wang Y: Childhood and juvenile meningiomas. Childs Nerv Syst 25:1571-1580, 2009
12. Greene S, Nair N, Ojemann JG, Ellenbogen RG, Avellino AM: Meningiomas in children. Pediatr Neurosurg 44:9-13, 2008
13. Guevara P, Escobar-Arriaga E, Saavedra-Perez D, Martinez-Rumayor A, Flores-Estrada D, Rembao D, et al: Angiogenesis and expression of estrogen and progesterone receptors as predictive factors for recurrence of meningioma. J Neurooncol 98:379-384, 2010
14. Jain D, Sharma MC, Sarkar C, Suri V, Garg A, Singh M, et al: Clear cell meningioma, an uncommon variant of meningioma: a clinicopathologic study of nine cases. J Neurooncol 81:315-321, 2007
15. Kotecha RS, Junckerstorff RC, Lee S, Cole CH, Gottardo NG: Pediatric meningioma: current approaches and future direction. J Neurooncol 104:1-10, 2011
16. Kotecha RS, Pascoe EM, Rushing EJ, Rorke-Adams LB, Zwerdling T, Gao X, et al: Meningiomas in children and adolescents: a meta-analysis of individual patient data. Lancet Oncol 12:1229-1239, 2011
17. Li X, Zhao J: Intracranial meningiomas of childhood and adolescence: report of 34 cases with follow-up. Childs Nerv Syst 25:1411-1417, 2009
18. Liu Y, Li F, Zhu S, Liu M, Wu C: Clinical features and treatment of meningiomas in children: report of 12 cases and literature review. Pediatr Neurosurg 44:112-117, 2008
19. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al: The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97-109, 2007
20. Mekitarian Filho E, Horigoshi NK, Carvalho WB, Hirscheimer MR, Bresolin AU, Leme RJ, et al: Primary spinal meningioma in a 10-year-old boy. Arq Neuropsiquiatr 68: 804-806, 2010
21. Menon G, Nair S, Sudhir J, Rao BR, Mathew A, Bahuleyan B: Childhood and adolescent meningiomas: a report of 38 cases and review of literature. Acta Neurochir (Wien) 151:239-244, 2009
22. Perry A, Louis DN, Scheithauer B, Budka H, von Diemling A: Meningiomas, in Louis DN, Ohgaki H, Wiestler OD, et al (eds): World Health Organization Classification of Tumours of the Central Nervous System, ed 4. Lyon: IARC Press, 2007, pp164-172
23. Perry A, Scheithauer BW, Stafford SL, Lohse CM, Wollan PC: "Malignancy" in meningiomas: a clinicopathologic study of 116 patients, with grading implications. Cancer 85:2046-2056, 1999
24. Prayson RA: Malignant meningioma: a clinicopathologic study of 23 patients including MIB1 and p53 immunohistochemistry. Am J Clin Pathol 105:719-726, 1996
25. Prayson RA, Chamberlain WA, Angelov L: Clear cell meningioma: a clinicopathologic study of 18 tumors and examination of the use of CD10, CA9, and RCC antibodies to distinguish between clear cell meningioma and metastatic clear cell renal cell carcinoma. Appl Immunohistochem Mol Morphol 18:422-428, 2010
26. Riemenschneider MJ, Perry A, Reifenberger G: Histological classification and molecular genetics of meningiomas. Lancet Neurol 5:1045-1054, 2006
27. Rushing EJ, Olsen C, Mena H, Rueda ME, Lee YS, Keating RF, et al: Central nervous system meningiomas in the first two decades of life: a clinicopathological analysis of 87 patients. J Neurosurg 103 (6 Suppl):489-495, 2005
28. Sandberg DI, Edgar MA, Resch L, Rutka JT, Becker LE, Souweidane MM: MIB-1 staining index of pediatric meningiomas. Neurosurgery 48:590-597, 2001
29. Shayanfar N, Mashayekh M, Mohammadpour M: Expression of progestrone receptor and proliferative marker ki 67 in various grades of meningioma. Acta Med Iran 48:142-147, 2010
30. Takei H, Buckleair LW, Powell SZ: Immunohistochemical expression of apoptosis regulating proteins and sex hormone receptors in meningiomas. Neuropathology 28:62-68, 2008
31. Traunecker H, Mallucci C, Grundy R, Pizer B, Saran F: Children's Cancer and Leukaemia Group (CCLG): guidelines for the management of intracranial meningioma in children and young people. Br J Neurosurg 22:13-25, 2008
32. Turgut M, Ozcan OE, Bertan V: Meningiomas in childhood and adolescence: a report of 13 cases and review of the literature. Br J Neurosurg 11:501-507, 1997
33. Weber DC, Lovblad KO, Rogers L: New pathology classification, imagery techniques and prospective trials for meningiomas: the future looks bright. Curr Opin Neurol 23:563-570, 2010
34. Wilson CB: Meningiomas: genetics, malignancy, and the role of radiation in induction and treatment. The Richard C. Schneider Lecture. J Neurosurg 81:666-675, 1994
35. Zorludemir S, Scheithauer BW, Hirose T, Van Houten C, Miller G, Meyer FB: Clear cell meningioma. A clinicopathologic study of a potentially aggressive variant of meningioma. Am J Surg Pathol 19:493-505, 1995